Brief: MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression

Emmaus Life Sciences

08/02/2018 12:31

Feb 8 (Reuters) - MYnd Analytics Inc  MYND.O : 
    * MYND ANALYTICS AWARDED CANADIAN PATENT ON NEUROMODULATION 
PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR 
TREATING DEPRESSION 
 
Source text for Eikon:  ID:nGNXOODWAa  
Further company coverage:  MYND.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))